Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology,
Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2026—As the scope and scale of information technology available to the pathology laboratory balloons, so too do the number of proposals for lab IT projects, products, and partnerships. And those pitching such proposals can up their odds of success if they avoid using technical jargon, acronyms, and other IT speak when explaining such endeavors to an audience without expertise in those areas, says communications expert Terry Rubin.
November 2025—UpToDate, a widely used clinical decision support tool, is facing competition from OpenEvidence, an AI-powered tool that provides more accurate and context-specific answers to complex clinical cases. While UpToDate is adding its own AI capabilities, the optimal source of truth for AI-driven clinical decision support remains uncertain.
October 2025—For pathology residents, there are easier tasks than writing a perfect preliminary case report on the first attempt. Nailing Jell-O to a tree, for example, or stapling sunlight to a cloud. “When the attendings make no changes or just sign out the case as we wrote it, there’s a sense of accomplishment,” says Jingjing Cao, MD, pathology resident in the Departments of Pathology and Laboratory Medicine, University of California San Francisco.
September 2025—In his previous role as a pathologist at Seattle’s Virginia Mason Medical Center, Dick Hwang, MD, PhD, was looking for a way to make his life—and his colleagues’ lives—easier. So he reached for something he hadn’t used in a while: his doctorate in computational biology. It was 2014, and Virginia Mason’s pathology group had just rolled out M*Modal Fluency Direct speech-recognition software as an optional tool for dictating diagnostic data. Dr. Hwang and many of his colleagues embraced the new software, but they soon realized that it meant they’d be spending a lot of time editing and formatting data. Entering a final diagnosis required, for example, typing “1.{tab}{caps lock},” dictating “cecum and ascending colon comma polypectomy,” then typing “:{caps lock}{return}{backspace}A.{tab}”—just as a start.
August 2025—Recognizing the value of researching options before purchasing a big-ticket item, the College of American Pathologists has developed the AI Playground to help pathologists assess artificial intelligence tools before going all-in on a technology that may not end up suiting their needs, among other potential issues. The playground will offer cutting-edge AI tools that pathologists can test-drive from the comfort of their own laboratories using simulated data sets on a platform designed specifically for that purpose. It will be available to CAP members at no charge and accessible via the CAP website after it is debuted in the CAP Innovation Hub and the College’s booth at CAP25, in Orlando, next month.
July 2025—PathAI and Chicago-based Northwestern Medicine have entered a multi-year venture in which Northwestern will implement PathAI’s AISight digital pathology image-management system. The two entities will also jointly undertake research initiatives and develop clinical innovation programs and artificial intelligence-powered diagnostic tools.
June 2025—Whether it’s easier to edit a document created by another source or create more or less the same document from scratch is open to debate. But clinical informaticians at Stanford Health Care, Palo Alto, Calif., are banking on clinicians preferring to assess and adjust versus starting with a blank page. Therefore, the health care system has been conducting trials on the use of generative artificial intelligence to draft patient-centric interpretations of pathology test results that these care providers can review and edit and then share with patients.
May 2025—Duke University has launched its Duke Center for Computational and Digital Health Innovation, which is intended to drive technological advances in the areas of wearable sensors, high-performance computing, and extended reality solutions. “Our center provides a vibrant platform for innovation and collaboration, where researchers, clinicians, engineers, and industry partners work side-by-side to pioneer new solutions,” says an open letter from Amanda Randles, PhD, director of the center. Faculty support for the center comes from the Duke University School of Medicine, School of Nursing, Trinity College of Arts and Sciences, and Pratt School of Engineering.
April 2025—UPMC Enterprises has introduced Ahavi, a real-world data platform on which clinical researchers, data scientists, and developers of artificial intelligence can validate AI solutions before the University of Pittsburgh Medical Center deploys them. The platform provides de-identified real-world health care data from more than 80 University of Pittsburgh Medical Center sources. Comprehensive structured and unstructured data have been sourced from approximately 5 million patients across 24 hospitals in order to train and refine AI models and develop predictive analytics and clinical decision-making tools.
March 2025—Delays while a courier is sent to the blood bank. Errors in judgment. Omission of steps in tracking who received a unit of blood. Wastage of blood product because clinicians were cautious and overordered or ordered too soon. Staffing issues. All of these potential blood bank-related problems can be mitigated with smart blood-storage devices, also called smart refrigerators or blood vending machines.
